View in EDS HTML Full Text PDF Full Text

Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels.

Saved in:
Bibliographic Details
Title: Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels.
Authors: Fajardo-Robledo, Nicte S.1 (AUTHOR), Jacobo-Cuevas, Heriberto2 (AUTHOR), Perez-Guerrero, Edsaul E.3 (AUTHOR), Corona-Sanchez, Esther G.4,5 (AUTHOR), Saldaña-Cruz, A. Miriam5 (AUTHOR), Romero-Tejeda, Elba M.6 (AUTHOR), Rodriguez-Jimenez, N. Alejandra5 (AUTHOR), Totsuka-Sutto, Sylvia E.5 (AUTHOR), Lopez-Roa, Rocio I.1 (AUTHOR), Ponce-Guarneros, Juan M.5,7 (AUTHOR), Alcaraz-Lopez, M. Fabiola8 (AUTHOR), Cerpa-Cruz, Sergio9 (AUTHOR), Muñoz-Valle, J. Francisco3 (AUTHOR), Cardona-Muñoz, E. German5 (AUTHOR), Gonzalez-Lopez, Laura2,5,10 (AUTHOR) dralauragonzalez@prodigy.net.mx, Gamez-Nava, Jorge I.2,5,10 (AUTHOR) ivangamezacademicoudg@gmail.com, Research Group for Factors Related to Therapeutic Outcomes in Autoimmune Diseases (AUTHOR), Fajardo-Robledo, Nicte Selene1 (AUTHOR), Saldaña-Cruz, Ana Miriam5 (AUTHOR), Rodriguez-Jimenez, Norma Alejandra5 (AUTHOR)
Source: Scientific Reports. 2/3/2022, Vol. 12 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-022-05644-7